dc.contributor.author |
Ramia S. |
dc.contributor.author |
El-zaatari M. |
dc.contributor.author |
Sharara A.I. |
dc.contributor.author |
Ramlawi F. |
dc.contributor.author |
Farhat B. |
dc.contributor.editor |
|
dc.date |
Aug-2007 |
dc.date.accessioned |
2017-10-18T13:38:21Z |
dc.date.available |
2017-10-18T13:38:21Z |
dc.date.issued |
2007 |
dc.identifier |
10.1017/S0950268806007643 |
dc.identifier.isbn |
|
dc.identifier.issn |
09502688 |
dc.identifier.uri |
http://hdl.handle.net/10938/20712 |
dc.description.abstract |
Recently the prevalence of hepatitis B virus (HBV) genotypes and the association between these genotypes and the clinical status of HBV-infected patients were recently investigated in the Lebanese population. The aim of the additional study reported here was to determine the current prevalence of hepatitis delta virus (HDV) infection and the range of HDV genotypes in this Lebanese population. Two hundred and fifty-eight HBsAg-positive patients (107 asymptomatic blood donors, 92 with chronic hepatitis, 24 with cirrhosis, 15 with hepatocellular carcinoma, 20 patients on haemodialysis) from ten medical centers in Lebanon were tested for antibody to hepatitis D virus (anti-HDV). Those testing positive were analysed further for HDV-RNA and for genotyping by reverse transcriptase-polymerase chain reaction (RT-PCR) and restriction fragment length polymorphism (RFLP). Three samples (1.2percent) were anti-HDV positive and out of these, only one was HDV-RNA positive (0.6percent) and was analysed as HDV genotype I. Our results point to a low endemicity of HDV in the Lebanese population which is in sharp contrast to data reported from Lebanon 20 years ago and to the situation in neighbouring Arab and non-Arab countries in the Mediterranean region. HDV genotype I seems to be the predominant genotype in Lebanon and the Middle East. © 2006 Cambridge University Press. |
dc.format.extent |
|
dc.format.extent |
Pages: (959-962) |
dc.language |
English |
dc.publisher |
NEW YORK |
dc.relation.ispartof |
Publication Name: Epidemiology and Infection; Publication Year: 2007; Volume: 135; no. 6; Pages: (959-962); |
dc.relation.ispartofseries |
|
dc.relation.uri |
|
dc.source |
Scopus |
dc.subject.other |
|
dc.title |
Current prevalence of hepatitis delta virus (HDV) infection and the range of HDV genotypes in Lebanon |
dc.type |
Article |
dc.contributor.affiliation |
Ramia, S., Faculty of Health Sciences, Department of Medical Laboratory Technology, American University of Beirut, PO Box 11-0236, Riad El Soloh 1107-2020 Beirut, Lebanon |
dc.contributor.affiliation |
El-zaatari, M., Department of Laboratory Medicine, Hamoud Hospital, Saida, Lebanon |
dc.contributor.affiliation |
Sharara, A.I., Faculty of Medicine, Department of Gastroenterology, American University of Beirut, PO Box 11-0236, Riad El Soloh 1107-2020 Beirut, Lebanon |
dc.contributor.affiliation |
Ramlawi, F., Faculty of Health Sciences, Department of Medical Laboratory Technology, American University of Beirut, PO Box 11-0236, Riad El Soloh 1107-2020 Beirut, Lebanon |
dc.contributor.affiliation |
Farhat, B., Department of Gastroenterology, Rasoul Al-Azam Hospital, Beirut, Lebanon |
dc.contributor.authorAddress |
Ramia, S.; Faculty of Health Sciences, American University of Beirut, PO Box 11-0236, Riad El Soloh 1107-2020 Beirut, Lebanon; email: sramia@aub.edu.lb |
dc.contributor.authorCorporate |
University: American University of Beirut; Faculty: Faculty of Health Sciences; Department: Medical Laboratory Sciences Program; |
dc.contributor.authorDepartment |
Medical Laboratory Sciences Program |
dc.contributor.authorDivision |
|
dc.contributor.authorEmail |
sramia@aub.edu.lb |
dc.contributor.faculty |
Faculty of Health Sciences |
dc.contributor.authorInitials |
Ramia, S |
dc.contributor.authorInitials |
El-Zaatari, M |
dc.contributor.authorInitials |
Sharara, AI |
dc.contributor.authorInitials |
Ramlawi, F |
dc.contributor.authorInitials |
Farhat, B |
dc.contributor.authorOrcidID |
|
dc.contributor.authorReprintAddress |
Ramia, S (reprint author), American Univ, Fac Hlth Sci, PO Box 11-0236,Riad El Soloh, Beirut 1107 2020, Lebanon. |
dc.contributor.authorResearcherID |
|
dc.contributor.authorUniversity |
American University of Beirut |
dc.description.cited |
Al Traif I, 2004, ANN SAUDI MED, V24, P343; BALIK I, 1991, EUR J EPIDEMIOL, V7, P48; Behzadian F, 2005, VIRUS GENES, V30, P383, DOI 10.1007-s11262-004-6782-z; CASEY JL, 1993, P NATL ACAD SCI USA, V90, P9016, DOI 10.1073-pnas.90.19.9016; CHAO YC, 1991, HEPATOLOGY, V13, P345, DOI 10.1016-0270-9139(91)92451-D; Cotrina M, 1998, J HEPATOL, V28, P971, DOI 10.1016-S0168-8278(98)80345-0; DAN M, 1993, INT J EPIDEMIOL, V22, P140, DOI 10.1093-ije-22.1.140; FARCI P, 1987, J HEPATOL, V4, P224, DOI 10.1016-S0168-8278(87)80084-3; Fattovich G, 2000, GUT, V46, P420, DOI 10.1136-gut.46.3.420; HADLER SC, 1991, PROG CLIN BIOL RES, V364, P21; Huo TI, 1997, J GASTROEN HEPATOL, V12, P747, DOI 10.1111-j.1440-1746.1997.tb00364.x; Huo TI, 2004, J MED VIROL, V72, P41, DOI 10.1002-jmv.10554; Ivaniushina V, 2001, J GEN VIROL, V82, P2709; Kao JH, 2002, J CLIN MICROBIOL, V40, P3047, DOI 10.1128-JCM.40.8.3047-3049.2002; Mast Eric E., 2005, Morbidity and Mortality Weekly Report, V54, P1; Mumtaz K, 2005, J GASTROEN HEPATOL, V20, P1503, DOI 10.1111-j.1440-1746.2005.03857.x; NABULSI MM, 2003, LEBAN MED J, V51, P51; Nakano T, 2001, J GEN VIROL, V82, P2183; REZVAN H, 1990, INFECTION, V18, P26, DOI 10.1007-BF01644177; RIZZETTO M, 1997, GUT, V189, P97; ROZDAYI AM, 2004, ARCH VIROL, V149, P2115; Sagnelli E, 1997, J HEPATOL, V26, P20, DOI 10.1016-S0168-8278(97)80004-9; Sakugawa H, 1999, J MED VIROL, V58, P366, DOI 10.1002-(SICI)1096-9071(199908)58:4366::AID-JMV83.0.CO;2-X; Saudy N, 2003, J MED VIROL, V70, P529, DOI 10.1002-jmv.10427; Shakil AO, 1997, VIROLOGY, V234, P160, DOI 10.1006-viro.1997.8644; Sharara AI, 2004, EUR J CLIN MICROBIOL, V23, P861, DOI 10.1007-s10096-004-1222-5; SMEDILE A, 1991, HEPATOLOGY, V13, P413; Taylor JM, 1999, INTERVIROLOGY, V42, P173, DOI 10.1159-000024977; Toukan A U, 1993, Prog Clin Biol Res, V382, P251; WU JC, 1995, LANCET, V346, P939, DOI 10.1016-S0140-6736(95)91558-3; Wu JC, 1998, J GEN VIROL, V79, P1105; WU JC, 1995, GASTROENTEROLOGY, V108, P796, DOI 10.1016-0016-5085(95)90453-0 |
dc.description.citedCount |
13 |
dc.description.citedTotWOSCount |
13 |
dc.description.citedWOSCount |
12 |
dc.format.extentCount |
4 |
dc.identifier.articleNo |
|
dc.identifier.coden |
EPINE |
dc.identifier.pubmedID |
17176498 |
dc.identifier.scopusID |
34748919446 |
dc.identifier.url |
|
dc.publisher.address |
32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA |
dc.relation.ispartofConference |
|
dc.relation.ispartofConferenceCode |
|
dc.relation.ispartofConferenceDate |
|
dc.relation.ispartofConferenceHosting |
|
dc.relation.ispartofConferenceLoc |
|
dc.relation.ispartofConferenceSponsor |
|
dc.relation.ispartofConferenceTitle |
|
dc.relation.ispartofFundingAgency |
|
dc.relation.ispartOfISOAbbr |
Epidemiol. Infect. |
dc.relation.ispartOfIssue |
6 |
dc.relation.ispartOfPart |
|
dc.relation.ispartofPubTitle |
Epidemiology and Infection |
dc.relation.ispartofPubTitleAbbr |
Epidemiol. Infect. |
dc.relation.ispartOfSpecialIssue |
|
dc.relation.ispartOfSuppl |
|
dc.relation.ispartOfVolume |
135 |
dc.source.ID |
WOS:000249150500011 |
dc.type.publication |
Journal |
dc.subject.otherAuthKeyword |
|
dc.subject.otherChemCAS |
|
dc.subject.otherIndex |
hepatitis antibody |
dc.subject.otherIndex |
hepatitis B surface antigen |
dc.subject.otherIndex |
virus RNA |
dc.subject.otherIndex |
adult |
dc.subject.otherIndex |
article |
dc.subject.otherIndex |
blood donor |
dc.subject.otherIndex |
chronic hepatitis |
dc.subject.otherIndex |
delta agent hepatitis |
dc.subject.otherIndex |
endemic disease |
dc.subject.otherIndex |
female |
dc.subject.otherIndex |
genotype |
dc.subject.otherIndex |
hemodialysis |
dc.subject.otherIndex |
Hepatitis delta virus |
dc.subject.otherIndex |
human |
dc.subject.otherIndex |
infection rate |
dc.subject.otherIndex |
Lebanon |
dc.subject.otherIndex |
liver cell carcinoma |
dc.subject.otherIndex |
liver cirrhosis |
dc.subject.otherIndex |
major clinical study |
dc.subject.otherIndex |
male |
dc.subject.otherIndex |
Middle East |
dc.subject.otherIndex |
nonhuman |
dc.subject.otherIndex |
prevalence |
dc.subject.otherIndex |
restriction fragment length polymorphism |
dc.subject.otherIndex |
reverse transcription polymerase chain reaction |
dc.subject.otherIndex |
Southern Europe |
dc.subject.otherIndex |
genetics |
dc.subject.otherIndex |
isolation and purification |
dc.subject.otherIndex |
virology |
dc.subject.otherIndex |
Adult |
dc.subject.otherIndex |
Female |
dc.subject.otherIndex |
Genotype |
dc.subject.otherIndex |
Hepatitis D |
dc.subject.otherIndex |
Hepatitis Delta Virus |
dc.subject.otherIndex |
Humans |
dc.subject.otherIndex |
Lebanon |
dc.subject.otherIndex |
Male |
dc.subject.otherIndex |
Prevalence |
dc.subject.otherKeywordPlus |
FRAGMENT-LENGTH-POLYMORPHISM |
dc.subject.otherKeywordPlus |
PHYLOGENETIC ANALYSIS |
dc.subject.otherKeywordPlus |
ENDEMIC AREA |
dc.subject.otherKeywordPlus |
TAIWAN |
dc.subject.otherKeywordPlus |
SEROEPIDEMIOLOGY |
dc.subject.otherKeywordPlus |
EPIDEMIOLOGY |
dc.subject.otherWOS |
Public, Environmental and Occupational Health |
dc.subject.otherWOS |
Infectious Diseases |